Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.4 USD | -3.98% | +4.12% | -7.19% |
May. 21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.19% | 17.51B | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-3.61% | 21.28B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B | |
+17.28% | 8.01B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Citigroup Initiates BeiGene With Buy Rating, $275 Price Target